Jeff Davies Acquires 879,687 Shares of Starpharma Holdings Limited (ASX:SPL) Stock

Starpharma Holdings Limited (ASX:SPL) insider Jeff Davies acquired 879,687 shares of the stock in a transaction dated Friday, June 28th. The stock was acquired at an average cost of A$0.09 ($0.06) per share, with a total value of A$80,051.52 ($53,367.68).

Starpharma Price Performance

The company has a debt-to-equity ratio of 9.08, a current ratio of 5.60 and a quick ratio of 5.65.

About Starpharma

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.